New Fujifilm cell banking facility commissioned in the U.K.

04/23/2013 | Genetic Engineering & Biotechnology News

Fujifilm Diosynth Biotechnologies' new cGMP mammalian cell banking facility in the U.K. has started operations. "I am delighted that we have commissioned the cell bank facility within a year of its commencement, and have already started work on our first customer program," FDB U.K. managing director Steve Bagshaw said. The firm plans to commission another cGMP plant at the site toward the end of the year.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX